Viewing Study NCT05197712

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2025-12-26 @ 10:19 PM
Study NCT ID: NCT05197712
Status: UNKNOWN
Last Update Posted: 2023-05-24
First Post: 2022-01-15
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Evaluation of the Safety, Tolerability, and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 Disease
Sponsor: Baiya Phytopharm Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 Vaccine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SARS-CoV-2 View
None SARS-CoV-2 vaccine View
None COVID-19 View
None COVID-19 Vaccine View